BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4043506)

  • 21. Combined radiation and chemotherapy for locally advanced transitional cell carcinoma of the urinary bladder.
    Jakse G; Frommhold H; zur Nedden D
    Cancer; 1985 Apr; 55(8):1659-64. PubMed ID: 4038912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Leiomyosarcoma of the bladder 8 years after radiation therapy for bladder cancer].
    Arutiunian NO; Figurin KM
    Urol Nefrol (Mosk); 1996; (3):45-6. PubMed ID: 8928334
    [No Abstract]   [Full Text] [Related]  

  • 23. [Proliferation effects of sirolimus, cyclosporine A and mycophenolate mofetil on human transitional cell carcinoma cells].
    Lin J; Wang YH; Zhang YH; Tian Y
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(6):388-91. PubMed ID: 22490898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Outcomes With Dose-Escalated Adaptive Radiation Therapy for Urinary Bladder Cancer: A Prospective Study.
    Murthy V; Masodkar R; Kalyani N; Mahantshetty U; Bakshi G; Prakash G; Joshi A; Prabhash K; Ghonge S; Shrivastava S
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):60-66. PubMed ID: 26547385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of a randomised study to evaluate influence of dose on morbidity in radiotherapy for bladder cancer.
    Quilty PM; Duncan W; Kerr GR
    Clin Radiol; 1985 Nov; 36(6):615-8. PubMed ID: 4064546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients.
    Fosså SD; Waehre H; Aass N; Jacobsen AB; Olsen DR; Ous S
    Cancer; 1993 Nov; 72(10):3036-43. PubMed ID: 8221571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinoma of the bladder treated by interstitial irradiation.
    Williams GB; Trott PA; Bloom HJ
    Br J Urol; 1981 Jun; 53(3):221-4. PubMed ID: 7248698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Characterization of a novel transplantable orthotopic nude mouse model with xenografted human bladder transitional cell tumor (BIU-87)].
    Li C; Yan RP; Yuan GH; Feng YG; Wang JS; Gao X; Huang YS; Zhou JB; Xie SS
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):733-6. PubMed ID: 17366782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Full-dose irradiation for invasive bladder cancer: prognostic factors and techniques.
    Shipley WU
    Urology; 1984 Apr; 23(4 Suppl):95-100. PubMed ID: 6424299
    [No Abstract]   [Full Text] [Related]  

  • 30. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
    Oliva E; Amin MB; Jimenez R; Young RH
    Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of therapeutic radiation with golgi complex hypertrophy in human urinary bladder carcinomas: quantitative electron microscopy studies.
    Alroy J; Pauli BU; Weinstein RS
    Ultrastruct Pathol; 1981; 2(1):43-52. PubMed ID: 16830448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.
    Moonen L; Ong F; Gallee M; Verheij M; Horenblas S; Hart AA; Bartelink H
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1305-10. PubMed ID: 11286838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Primary culture of human bladder carcinomas and establishment of human bladder carcinoma cell line by serum-free culture].
    Ito H; Yamaguchi K; Kotake T; Matsuzaki O
    Nihon Hinyokika Gakkai Zasshi; 1989 Dec; 80(12):1749-54. PubMed ID: 2625822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific red cell adherence testing and radiotherapy.
    Stein BS; Kendall AR
    Cancer; 1982 Dec; 50(11):2329-32. PubMed ID: 7139529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a newly established human urinary bladder cancer cell line (BT-1).
    Heckl W; Köhler J; Hoehn H; Dämmrich J
    Urol Res; 1988; 16(1):23-9. PubMed ID: 3344562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoantigens A, B and H in urinary bladder carcinomas following radiotherapy.
    Alroy J; Teramura K; Miller AW; Pauli BU; Gottesman JE; Flanagan M; Davisohn I; Weinstein RS
    Cancer; 1978 May; 41(5):1739-45. PubMed ID: 647623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimum fractionation for irradiation of carcinoma of the bladder. Experiments based on one case.
    Mohiuddin M; McDay J; Leeper D; Kramer S
    Acta Radiol Oncol Radiat Phys Biol; 1979; 18(1):11-6. PubMed ID: 433655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of radiotherapy in cancer of the bladder in Saguenay-Lac Saint-Jean].
    Brochet F; Barrette LR
    Cancer Radiother; 1998 Apr; 2 Suppl 1():49s-53s. PubMed ID: 9749079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation.
    Price P; McMillan TJ
    Cancer Res; 1990 Mar; 50(5):1392-6. PubMed ID: 2302704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemosensitivity of KK-47 bladder cancer cells and KN-41 renal cancer cells heterotransplanted in nude mice].
    Koizumi H
    Nihon Hinyokika Gakkai Zasshi; 1983 May; 74(5):704-18. PubMed ID: 6620776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.